Page results
-
Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
UCLH will play a vital role in a new respiratory virus study.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
UCLH has declared a climate and health emergency, and has published a 10-point climate action plan to reach net zero carbon dioxide emissions by 2031.
-
The diabetes team have revisited their tips for managing diabetes over the Christmas holidays and updated them for 2022.
-
Information about our UCLH Charity, charity funds and associated charities.
-
Our staff have rated UCLH as the top trust in England, improving on our ranking from last year when we were third best in England and top in London.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
File results
-
FOI/2024/0210 - Clear identification of registered nurses/ job title on badges
-
FOI/2024/0554 - Robotic Process Automation (RPA) Programme
-
FOI/2024/0475 - Prophylactic hydrocortisone neonatal deaths in 2023
-
FOI/2024/0091 - Primary HIFU PA procedures/ salvage HIFU procedures HEAT registry
-
FOI/2024/0548 - Patient transport services, providers/ charges
-
FOI/2024/0550 - Syntometrine vs Misoprostol/ treatment uses for post-partum haemorrhage
-
FOI/2024/0559 - Surgical Robots purchase/ simulators/ procedures 2019-2024
-
FOI/2024/0560 - Coroners' Prevention of Future Deaths Reports
-
FOI/2024/0561 - Gender reassignment and/or transgender policies, mixed/same sex accommodation and Equality Impact Assessments (EIA)
-
FOI/2024/0564 - Transperineal prostate biopsies undertaken in 2023